Skip to content

Holmes sees a reduction in her sentence duration.

Elizabeth Holmes, the disgraced ex-CEO of Theranos, may be freed from prison well ahead of schedule, based on the predicted release date displayed by the Bureau of Prisons.

Elizabeth Holmes, left, arrives at Federal Prison Camp Bryan in Bryan, Texas in May 2023.
Elizabeth Holmes, left, arrives at Federal Prison Camp Bryan in Bryan, Texas in May 2023.

Holmes sees a reduction in her sentence duration.

The Bureau of Prisons' current records show that Holmes' projected release date from a Texas prison is now August 16, 2032, which is slightly earlier than her previous scheduled release of December 29, 2032.

This reduction in her expected release time is the second one she's experienced in less than a year. Her 11-year and three-month sentence was shortened by nearly two years last July.

The Bureau of Prisons did not provide a statement to CNN regarding this change, but it's important to note that inmates can earn good conduct time which is factored into their estimated release date. Inmates who qualify can acquire up to 54 days of Good Conduct Time Credit for each year of their sentence.

There are also other ways for prisoners to earn time credits through participating in prison programs. These methods for calculating projected release dates are not unique to Holmes' case, but are standard practice across the prison system.

Holmes is currently serving her sentence at Federal Prison Camp Bryan, a minimum security federal prison camp located approximately 100 miles from Houston. Her request to remain out on bail while she fights to overturn her conviction was rejected by an appellate court in May 2023.

Holmes was once a highly-revered figure in the tech industry, embodying the limitless aspirations and possibilities of Silicon Valley. Now, she's one of the few tech executives to find herself behind bars after being found guilty of defrauding investors while managing Theranos.

Truth be told, Theranos reached its highest value at $9 billion, giving Holmes a paper billionaire status. However, the company started to fall apart after a Wall Street Journal investigation in 2015 revealed that they had only performed around a dozen of the hundreds of tests they claimed to offer using their proprietary technology, and with questionable accuracy. Additionally, it was discovered that Theranos was relying on third-party manufactured devices from traditional blood testing companies rather than their own technology.

Read also:

Source: edition.cnn.com

Comments

Latest